Mishra A, Juneja D. Deciphering the iron enigma: Navigating the complexities of iron metabolism in critical illness. World J Clin Cases 2024; 12(27): 6027-6031 [PMID: 39328848 DOI: 10.12998/wjcc.v12.i27.6027]
Corresponding Author of This Article
Deven Juneja, DNB, FRCP, MBBS, Director, Department of Critical Care Medicine, Max Super Speciality Hospital, 1 Press Enclave Road, Saket, New Delhi 110017, India. devenjuneja@gmail.com
Research Domain of This Article
Critical Care Medicine
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Sep 26, 2024; 12(27): 6027-6031 Published online Sep 26, 2024. doi: 10.12998/wjcc.v12.i27.6027
Deciphering the iron enigma: Navigating the complexities of iron metabolism in critical illness
Anjali Mishra, Deven Juneja
Anjali Mishra, Department of Critical Care Medicine, Holy Family Hospital, Delhi 110025, India
Deven Juneja, Department of Critical Care Medicine, Max Super Speciality Hospital, New Delhi 110017, India
Author contributions: Mishra A and Juneja D performed the writing, data accusation, and reviewed the manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Deven Juneja, DNB, FRCP, MBBS, Director, Department of Critical Care Medicine, Max Super Speciality Hospital, 1 Press Enclave Road, Saket, New Delhi 110017, India. devenjuneja@gmail.com
Received: May 2, 2024 Revised: May 30, 2024 Accepted: June 20, 2024 Published online: September 26, 2024 Processing time: 89 Days and 19.8 Hours
Abstract
Iron is a double-edged sword! Despite being essential for numerous physiological processes of the body, a dysregulated iron metabolism can result in tissue damage, exaggerated inflammatory response, and increased susceptibility to infection with certain pathogens that thrive in iron-rich environment. During sepsis, there is an alteration of iron metabolism, leading to increased transport and uptake into cells. This increase in labile iron may cause oxidative damage and cellular injury (ferroptosis) which progresses as the disease worsens. Critically ill patients are often complicated with systemic inflammation which may contribute to multiple organ dysfunction syndrome or sepsis, a common cause of mortality in intensive care unit. Originally, ferritin was known to play an important role in the hematopoietic system for its iron storage capacity. Recently, its role has emerged as a predictor of poor prognosis in chronic inflammation and critical illnesses. Apart from predicting the disease outcome, serum ferritin can potentially reflect disease activity as well.
Core Tip: Traditionally serum iron parameters including ferritin have served as biomarkers for assessing the iron status. Recently, the spectrum of utility for these markers has widened as tools for assessing inflammation and predicting outcomes in critically ill patients. These markers have been associated with high mortality and poor clinical outcomes in various critical illnesses. Serial measurement of iron parameters, especially in patients admitted to intensive care units, may be used as potential tools to determine worsening and progression towards multiorgan failure. However, their interpretation must be in accordance with the patient's clinical condition and other biochemical parameters, for guiding further treatment to optimize clinical care and prognosis.